大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/08/07 | 3,746 | 3,832 | 3,745 | 3,824 | +99 | +2.7% | 1,251,100 |
2019/08/06 | 3,669 | 3,747 | 3,636 | 3,725 | -90 | -2.4% | 1,143,600 |
2019/08/05 | 3,825 | 3,846 | 3,751 | 3,815 | -21 | -0.5% | 1,074,200 |
2019/08/02 | 3,868 | 3,897 | 3,818 | 3,836 | -102 | -2.6% | 1,332,400 |
2019/08/01 | 3,953 | 3,956 | 3,901 | 3,938 | -79 | -2% | 938,300 |
2019/07/31 | 4,024 | 4,042 | 3,965 | 4,017 | -11 | -0.3% | 1,745,300 |
2019/07/30 | 3,941 | 4,030 | 3,906 | 4,028 | +169 | +4.4% | 1,612,600 |
2019/07/29 | 3,875 | 3,899 | 3,838 | 3,859 | -20 | -0.5% | 608,800 |
2019/07/26 | 3,866 | 3,881 | 3,857 | 3,879 | +13 | +0.3% | 874,100 |
2019/07/25 | 3,915 | 3,918 | 3,856 | 3,866 | -40 | -1% | 789,800 |
2019/07/24 | 3,924 | 3,931 | 3,888 | 3,906 | +8 | +0.2% | 1,142,500 |
2019/07/23 | 3,853 | 3,907 | 3,838 | 3,898 | +45 | +1.2% | 761,600 |
2019/07/22 | 3,862 | 3,877 | 3,819 | 3,853 | -12 | -0.3% | 809,400 |
2019/07/19 | 3,773 | 3,868 | 3,766 | 3,865 | +102 | +2.7% | 809,200 |
2019/07/18 | 3,815 | 3,822 | 3,749 | 3,763 | -59 | -1.5% | 1,007,100 |
2019/07/17 | 3,831 | 3,852 | 3,809 | 3,822 | -28 | -0.7% | 701,200 |
2019/07/16 | 3,870 | 3,890 | 3,831 | 3,850 | -21 | -0.5% | 805,600 |
2019/07/12 | 3,859 | 3,871 | 3,804 | 3,871 | +23 | +0.6% | 1,141,500 |
2019/07/11 | 3,860 | 3,877 | 3,839 | 3,848 | -38 | -1% | 989,600 |
2019/07/10 | 3,832 | 3,888 | 3,816 | 3,886 | +19 | +0.5% | 1,097,800 |
2019/07/09 | 3,880 | 3,897 | 3,852 | 3,867 | +51 | +1.3% | 1,195,300 |
2019/07/08 | 3,886 | 3,892 | 3,794 | 3,816 | -55 | -1.4% | 1,627,200 |
2019/07/05 | 3,882 | 3,888 | 3,849 | 3,871 | +12 | +0.3% | 1,199,500 |
2019/07/04 | 3,862 | 3,902 | 3,837 | 3,859 | +67 | +1.8% | 1,633,400 |
2019/07/03 | 3,737 | 3,794 | 3,729 | 3,792 | +93 | +2.5% | 1,517,400 |
2019/07/02 | 3,704 | 3,720 | 3,645 | 3,699 | +11 | +0.3% | 1,233,400 |
2019/07/01 | 3,586 | 3,698 | 3,585 | 3,688 | +172 | +4.9% | 1,806,600 |
2019/06/28 | 3,510 | 3,578 | 3,499 | 3,516 | +17 | +0.5% | 1,840,400 |
2019/06/27 | 3,465 | 3,499 | 3,434 | 3,499 | +5 | +0.1% | 1,509,300 |
2019/06/26 | 3,495 | 3,514 | 3,484 | 3,494 | -71 | -2% | 1,121,900 |
2019/06/25 | 3,609 | 3,621 | 3,562 | 3,565 | -43 | -1.2% | 1,088,500 |
2019/06/24 | 3,578 | 3,615 | 3,570 | 3,608 | +46 | +1.3% | 658,200 |
2019/06/21 | 3,617 | 3,640 | 3,555 | 3,562 | -60 | -1.7% | 1,408,800 |
2019/06/20 | 3,604 | 3,684 | 3,594 | 3,622 | +51 | +1.4% | 1,238,900 |
2019/06/19 | 3,557 | 3,600 | 3,553 | 3,571 | +25 | +0.7% | 1,144,600 |
2019/06/18 | 3,618 | 3,626 | 3,541 | 3,546 | -43 | -1.2% | 973,400 |
2019/06/17 | 3,619 | 3,629 | 3,589 | 3,589 | -58 | -1.6% | 820,800 |
2019/06/14 | 3,672 | 3,675 | 3,627 | 3,647 | -23 | -0.6% | 1,278,700 |
2019/06/13 | 3,720 | 3,720 | 3,650 | 3,670 | -78 | -2.1% | 1,020,600 |
2019/06/12 | 3,721 | 3,769 | 3,716 | 3,748 | +28 | +0.8% | 863,700 |
2019/06/11 | 3,666 | 3,722 | 3,650 | 3,720 | +25 | +0.7% | 958,500 |
2019/06/10 | 3,728 | 3,759 | 3,681 | 3,695 | +5 | +0.1% | 1,061,200 |
2019/06/07 | 3,740 | 3,766 | 3,683 | 3,690 | -48 | -1.3% | 924,900 |
2019/06/06 | 3,689 | 3,756 | 3,683 | 3,738 | +48 | +1.3% | 1,234,600 |
2019/06/05 | 3,753 | 3,773 | 3,677 | 3,690 | +39 | +1.1% | 1,471,400 |
2019/06/04 | 3,615 | 3,666 | 3,609 | 3,651 | +63 | +1.8% | 1,348,700 |
2019/06/03 | 3,576 | 3,597 | 3,556 | 3,588 | -58 | -1.6% | 1,288,500 |
2019/05/31 | 3,659 | 3,733 | 3,637 | 3,646 | -44 | -1.2% | 1,580,000 |
2019/05/30 | 3,742 | 3,746 | 3,682 | 3,690 | -76 | -2% | 1,223,100 |
2019/05/29 | 3,800 | 3,816 | 3,732 | 3,766 | -75 | -2% | 1,080,800 |
1401~
1450
件表示中 / 3518件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム